Business Context and Reporting Period
Company: Chicago Atlantic BDC, Inc. (LIEN)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended March 31, 2026
Business Overview: An externally managed, closed-end business development company (BDC) and regulated investment company (RIC) focused on investing in the cannabis ecosystem, growth and technology companies, and esoteric asset-based lending. The company primarily invests in secured debt, unsecured debt, equity warrants, and direct equity in privately held businesses.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Assets | $373.1 million | $342.0 million |
| Total Investments (Fair Value) | $364.0 million | $333.3 million |
| Net Investment Income | $9.96 million | $7.65 million |
| Net Increase in Net Assets from Operations | $8.54 million | $7.61 million |
| Net Asset Value (NAV) per Share | $13.33 | $13.19 |
| Net Investment Income per Share | $0.44 | $0.34 |
| Debt (Revolving Line of Credit) | $54.5 million | $25.0 million |
| Cash and Cash Equivalents | $3.35 million | $2.93 million |
| Asset Coverage Ratio | 658% | N/A |
Material Changes vs. Prior Period
- Portfolio Growth: Total investment portfolio fair value increased by approximately 9.2% ($30.7 million) from Q1 2025 to Q1 2026, driven by $92.7 million in new purchases and accretion, partially offset by $63.4 million in repayments and sales.
- Income Growth: Total investment income rose 40.1% to $16.7 million, primarily due to a larger portfolio size and increased fee income ($2.1 million vs. $0.6 million).
- Expense Increase: Net operating expenses increased 57.7% to $6.74 million. This was driven by higher interest expense ($1.02 million vs. $0.15 million) due to increased leverage and higher incentive fees. Notably, expense waivers and limitation agreements present in Q1 2025 ($0.97 million total) expired and were not present in Q1 2026.
- Unrealized Losses: The company recorded a net change in unrealized depreciation of $1.43 million, compared to $34,000 in the prior year period. Significant unrealized depreciation was noted in several cannabis portfolio companies, including Dreamfields Brands, AI Software, and Canopy Growth warrants.
- Leverage: Borrowings under the revolving line of credit more than doubled from $25.0 million to $54.5 million to fund new investments.
Guidance, Outlook, Risks, and Unusual Items
- Regulatory Environment: The filing highlights a significant shift in federal policy regarding cannabis. On April 23, 2026, the DEA issued an order to reclassify certain medical cannabis products from Schedule I to Schedule III. While this may improve after-tax cash flows for some borrowers, the company notes uncertainty regarding the application to integrated medical and adult-use operations and potential increased competition for capital.
- Dividend Policy: The company declared a quarterly dividend of $0.34 per share for Q1 2026. The Dividend Reinvestment Plan (DRIP) was terminated effective December 31, 2025; all future distributions are paid in cash.
- Expense Cap Expiration: The Expense Limitation Agreement, which capped operating expenses at 2.15% of net assets, expired on September 30, 2025, and was not renewed. This contributed to the increase in net expenses for the current quarter.
- Market Discount: As of May 13, 2026, the common stock traded at $9.07, representing a discount of approximately 32% to the NAV of $13.33.
- Subsequent Events: On May 12, 2026, the Board approved a cash dividend of $0.34 per share payable July 10, 2026. A shelf registration statement for up to $500 million in securities was filed on May 11, 2026.
Investor Verification Checklist
- Cannabis Regulatory Impact: Verify the specific impact of the April 2026 DEA rescheduling order on the company's top cannabis portfolio companies, particularly those with mixed medical and adult-use operations.
- Expense Trajectory: Monitor future expense ratios given the expiration of the expense limitation agreement and the absence of expense waivers in the current quarter.
- Portfolio Concentration: Review the concentration risk, as the top three portfolio companies represented 32.5% of the portfolio's fair value as of March 31, 2026.
- Liquidity and Leverage: Assess the sustainability of the increased leverage (borrowings up to $54.5 million) and the company's ability to service debt while maintaining the 150% asset coverage requirement under the 1940 Act.
- Unrealized Depreciation Drivers: Investigate the specific reasons for the $1.43 million in unrealized depreciation, particularly the valuation adjustments for AI Software, LLC and Canopy Growth Corporation warrants.